Skip to main content

Share story

Policy

IonQ Gets Final Regulatory Approval for SkyWater Deal

IonQ logo. IonQ has received final regulatory approval to close its acquisition of SkyWater Technology. Image: Primary
Quantum computing company IonQ said Tuesday it has secured final regulatory clearance to close its acquisition of U.S.-based semiconductor foundry SkyWater Technology. IonQ said it expects the transaction to close on Friday, July 31. SkyWater will operate as a wholly owned IonQ subsidiary under its own name and will keep serving its existing customer base. IonQ said its proprietary technology and development services will work alongside SkyWater's manufacturing capabilities to serve the broader quantum ecosystem. In January, IonQ agreed to acquire SkyWater to form a vertically integrated, full-stack quantum platform company. SkyWater stockholders approved the merger in May. SkyWater is a Defense Microelectronics Activity-accredited Category 1A Trusted Foundry with facilities in Minnesota, Florida and Texas.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from GovCon Wire and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Former Benchmark investors raise $1.252 billion for Diffusion ONE

Former Benchmark investors Victor Lazarte and Kris Fredrickson have raised $1.252 billion for their debut AI fund, Diffusion ONE, TechCrunch reported from SEC filings. The total exceeds the $800 million target Forbes reported in M...

Infrastructure Products
Infrastructure Products

ASM raises 2027 revenue forecast to more than €5.7B

ASM International raised its 2027 revenue forecast to more than €5.7B from above €4.6B forecast in July, as memory and advanced AI chipmakers expand production. The chip-equipment maker said the revised outlook would reach its 203...

Capital AI
Capital AI

Anthropic acquires Mithril Medicine and starts its own drug research

Anthropic says it has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, and begun running drug discovery programs itself. Founder Cody Tranbarger is continuing the rese...

Capital AI
Capital AI

Avante raises $30M Series A for employee benefits platform

Avante raised a $30M Series A for its AI platform that helps companies manage employee healthcare and other benefits, GeekWire reported. The financing follows a $10M seed round in 2024 and adds capital to the employee benefits sof...